Chinese biopharmaceutical firm CARsgen bags $186m Series C led by Loyal Valley

Chinese biopharmaceutical firm CARsgen bags $186m Series C led by Loyal Valley

Photo by Brett Jordan on Unsplash

02 November, 2020

Loyal Valley Capital Therapeutics Holdings

Printed by Unregistered user on Sat, 26 Jul 2025 16:22:08 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Chinese PE firm Loyal Valley Capital raises $465m for second USD fund

Venture Capital

Chinese biopharma startup Sinovent closes $145m Series C round

Read more from Greater China

Hong Kong IPO boom triggers price war among banks

Chinese e-commerce giants defend ‘instant retail’ strategy despite state pressure